HLN Haleon Corp Earnings per share increase in current year

HLN (Haleon Corp) - company brandmark

Haleon plc dominates the over-the-counter segment, which allows the company to confidently index product prices without losing customers. Comparing the annual EPS growth trajectory on GURU.Markets, we see that the value remains at 9.40. Global networks stabilize costs, yet currency volatility and geopolitical-driven logistical disruptions in Asia continue to pressure the business's bottom-line profitability.

HLN (Haleon) Earnings growth in current year history from 04/28/2023 to 11/17/2026
Finished products of Haleon Group

This indicator measures the annual growth rate of earnings per share, allowing investors to assess the actual efficiency of business capitalization without the influence of market volatility. By analyzing the annual EPS trend, one can determine how effectively Haleon plc (HLN) converts consumer trust and pharmacy dominance into profit growth while overcoming high marketing costs and certification expenses for new drugs.

Main competitors

Kenvue Corp - Earnings per share increase in current year|VRNA (Verona Pharma PLC) - Earnings growth in current year|Earnings per share growth rate in current year jyongbio.com MENS|Earnings per share growth in current year Ligand (LGND)|AMRX (Amneal) - Earnings per share increase in current year|Earnings per share growth in current year Perrigo PRGO|Earnings growth in current year Alvotech Biopharmaceuticals ALVO|liquidia.com - Earnings growth in current year|GLPG - Earnings growth in current year|ANIP: Earnings growth in current year|Earnings per share growth this year MNKD|AMPH (Amphastar) - Earnings growth in current year|Pacira Corp (PCRX) - Expected net earnings per share growth this year|Earnings per share growth in current year ARS Pharma (SPRY)|Earnings growth in current year Theravance Biopharma, Inc. (TBPH)|Aquestive Therapeutics - Net earnings per share growth this year|Earnings per share increase in current year SCPH|Tectonic Therapeutic Inc. - Earnings growth in current year|Earnings per share trend in current year TNXP|SXTC (China SXT Pharmaceuticals) - Net earnings per share growth this year|Eupraxia Pharmaceuticals (EPRX) - Earnings growth in current year|Earnings per share growth in current year BioHarvest Sciences, Inc.|EXOZ: Earnings per share increase in current year|Earnings growth in current year ORMP|ENTX - Earnings per share growth rate in current year|Earnings per share growth in current year MindWalk Holdings, Inc. HYFT|Earnings growth in current year abvcpharma.com ABVC|CPIX - Earnings per share growth in current year|Earnings per share trend in current year QNTM|FGEN (FibroGen Corporation) - Net earnings per share growth this year|Net earnings per share growth this year Telomir Pharma|Net earnings per share growth this year RANI|Earnings per share growth rate in current year synergychc.com SNYR|Earnings per share growth in current year Rallybio Corp (RLYB)|LEXX - Earnings per share growth rate in current year|Pulmatrix Inc - Net earnings per share growth this year|Earnings per share increase in current year PTHL|Aptorum Group Ltd - Earnings growth in current year|Expected net earnings per share growth this year Lyra Therapeutics LYRA|IBO: Earnings growth in current year|TNFA (TNF Pharma) - Earnings per share growth in current year|Earnings per share growth in current year cbdmd.com|Earnings per share growth this year PRFX (PainReform Corp)|Earnings growth in current year CYTO|Net earnings per share growth this year Lipella Pharmaceuticals LIPO|Earnings per share growth in current year OptiNose OPTN|Pieris Pharmaceuticals Inc - Earnings per share growth in current year|Procaps Group Corp - Earnings growth in current year|Expected net earnings per share growth this year Petros Pharma PTPI|Qilian International Holding Group Limited (QLI) - Earnings per share growth in current year|ACELYRIN (SLRN) - Earnings growth in current year|Earnings per share growth in current year TFF Pharmaceuticals